Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention in people with inflammatory arthritis: study protocol of the Physiotherapy WORKs trial. (2023)
https://pubmed.ncbi.nlm.nih.gov/37730637

Fatigue in patients with rheumatic and musculoskeletal diseases: a scoping review on definitions, measurement instruments, determinants, consequences and interventions (2023)
https://pubmed.ncbi.nlm.nih.gov/37541741/

Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry (2023)
https://pubmed.ncbi.nlm.nih.gov/37453735/

The value of correctly diagnosing axial spondyloarthritis for patients and society (2023)
https://pubmed.ncbi.nlm.nih.gov/37451047/

Development of a web-based decision aid for initiating biological or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37263741/

Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials (2023)
https://pubmed.ncbi.nlm.nih.gov/36725056/

Effectiveness and cost-effectiveness of combined asynchronous telemonitoring and patient-initiated care for spondyloarthritis: protocol for a pragmatic multicentre randomised controlled trial (TeleSpA Study) (2023)
https://pubmed.ncbi.nlm.nih.gov/36806136/

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation (2023)
https://pubmed.ncbi.nlm.nih.gov/36596655/

Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review (2023)
https://pubmed.ncbi.nlm.nih.gov/36434893/

The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter? (2023)
https://pubmed.ncbi.nlm.nih.gov/36205588/

Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT (2023)
https://pubmed.ncbi.nlm.nih.gov/36099046/

Instrument selection for the ASAS core outcome set for axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/35680390/

Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry (2022)
https://pubmed.ncbi.nlm.nih.gov/36109082/

Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals (2022)
https://pubmed.ncbi.nlm.nih.gov/35438147/

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34534275/

Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA study (2022)
https://pubmed.ncbi.nlm.nih.gov/34387300/

Performance of 3 Composite Measures for Disease Activity in Peripheral Spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34470791/

Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT (2022)
https://pubmed.ncbi.nlm.nih.gov/36099046/

The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter? (2022)
https://pubmed.ncbi.nlm.nih.gov/36205588/

Instrument selection for the ASAS core outcome set for axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35680390/

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs (2022)
https://pubmed.ncbi.nlm.nih.gov/35654458/

Are All Routine Spondyloarthritis Outpatient Visits Considered Useful by Rheumatologists? An Exploratory Clinical Practice Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35649557/

Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs (2022)
https://pubmed.ncbi.nlm.nih.gov/35361692/

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs (2022)
https://pubmed.ncbi.nlm.nih.gov/35351808/

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases (2022)
https://pubmed.ncbi.nlm.nih.gov/35260387/

How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort (2022)
https://pubmed.ncbi.nlm.nih.gov/34320627/

Treat-to-target in axial spondyloarthritis: an observational study in daily practice (2022)
https://pubmed.ncbi.nlm.nih.gov/34175950/

Do tender joints in active psoriatic arthritis reflect inflammation assessed by ultrasound and magnetic resonance imaging? (2022)
https://pubmed.ncbi.nlm.nih.gov/33895799/

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial (2022)
https://pubmed.ncbi.nlm.nih.gov/33044756/

Tapering or discontinuation of biological disease-modifying antirheumatic drugs in axial spondyloarthritis: A review of the literature and discussion on current practice (2022)
https://pubmed.ncbi.nlm.nih.gov/36336291/

Are All Routine Spondyloarthritis Outpatient Visits Considered Useful by Rheumatologists? An Exploratory Clinical Practice Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35649557/

Exploring discordance between Health Literacy Questionnaire scores of people with RMDs and assessment by treating health professionals (2022)
https://pubmed.ncbi.nlm.nih.gov/35438147/

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases (2022)
https://pubmed.ncbi.nlm.nih.gov/35260387/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey (2021)
https://pubmed.ncbi.nlm.nih.gov/34334361/

Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort (2021)
https://pubmed.ncbi.nlm.nih.gov/34172511/

Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: Analysis of the ASAS-perSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34153894/

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33958325/

A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33589554/

Addressing Health Literacy Needs in Rheumatology: Which Patient Health Literacy Profiles Need the Attention of Health Professionals? (2021)
https://pubmed.ncbi.nlm.nih.gov/33026713/

Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies (2021)
https://pubmed.ncbi.nlm.nih.gov/32669450/

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT) (2020)
https://pubmed.ncbi.nlm.nih.gov/32993799/

(Health-Related) Quality of Life as an Outcome in Studies of Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32340709/

Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands (2020)
https://pubmed.ncbi.nlm.nih.gov/32318970/

Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study (2020)
https://pubmed.ncbi.nlm.nih.gov/31665462/

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/

Depression in ankylosing spondylitis and the role of disease-related and contextual factors: a cross-sectional study (2019)
https://pubmed.ncbi.nlm.nih.gov/31639012/

Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HI (2019)
https://pubmed.ncbi.nlm.nih.gov/31245046/

Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net) (2019)
https://pubmed.ncbi.nlm.nih.gov/31168405/

Individual-level and country-level socioeconomic determinants of disease outcomes in SpA: multinational, cross-sectional study (ASAS-COMOSPA) (2019)
https://pubmed.ncbi.nlm.nih.gov/30674477/

International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group (2019)
https://pubmed.ncbi.nlm.nih.gov/30358135/

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life (2018)
https://pubmed.ncbi.nlm.nih.gov/30487997/

Employment and the role of personal factors among patients with ankylosing spondylitis: a Dutch cross-sectional case-control study (2018)
https://pubmed.ncbi.nlm.nih.gov/30018801/

Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study (2018)
https://pubmed.ncbi.nlm.nih.gov/29860232/

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29858176/

Are globals for health, well-being and quality of life interchangeable? A mixed methods study in ankylosing spondylitis patients and controls (2018)
https://pubmed.ncbi.nlm.nih.gov/29788458/

Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons (2018)
https://pubmed.ncbi.nlm.nih.gov/29465359/

Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work (2018)
https://pubmed.ncbi.nlm.nih.gov/29373701/

Social Role Participation and Satisfaction With Life: A Study Among Patients With Ankylosing Spondylitis and Population Controls (2018)
https://pubmed.ncbi.nlm.nih.gov/28622457/

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach (2018)
https://pubmed.ncbi.nlm.nih.gov/28575536/

Work outcome in yet undiagnosed patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis; results of a cross-sectional study among patients with chronic low back pain (2017)
https://pubmed.ncbi.nlm.nih.gov/28623950/

OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients? (2017)
https://pubmed.ncbi.nlm.nih.gov/28298567/

Patient-reported Flares in Ankylosing Spondylitis: A Cross-sectional Analysis of 234 Patients (2017)
https://pubmed.ncbi.nlm.nih.gov/27980007/

Social Role Participation in Patients With Ankylosing Spondylitis: A Cross-Sectional Comparison With Population Controls (2016)
https://pubmed.ncbi.nlm.nih.gov/27059161/

Electronic assessment of disease activity and functioning in patients with axial spondyloarthritis: challenges and unmet needs (2016)
https://pubmed.ncbi.nlm.nih.gov/27762203/

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016)
https://pubmed.ncbi.nlm.nih.gov/27752358/